178 related articles for article (PubMed ID: 31565698)
21. Triggering receptor expressed on myeloid cells 2 (TREM2) dependent microglial activation promotes cisplatin-induced peripheral neuropathy in mice.
Hu LY; Zhou Y; Cui WQ; Hu XM; Du LX; Mi WL; Chu YX; Wu GC; Wang YQ; Mao-Ying QL
Brain Behav Immun; 2018 Feb; 68():132-145. PubMed ID: 29051087
[TBL] [Abstract][Full Text] [Related]
22. Evidence and Function Relevance of Native DOR-MOR Heteromers.
Cahill CM; Ong E
Handb Exp Pharmacol; 2018; 247():115-127. PubMed ID: 29633181
[TBL] [Abstract][Full Text] [Related]
23. Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors.
Ong EW; Cahill CM
Cells; 2014 Mar; 3(1):152-79. PubMed ID: 24709907
[TBL] [Abstract][Full Text] [Related]
24. Neuropathic pain is enhanced in delta-opioid receptor knockout mice.
Nadal X; Baños JE; Kieffer BL; Maldonado R
Eur J Neurosci; 2006 Feb; 23(3):830-4. PubMed ID: 16487163
[TBL] [Abstract][Full Text] [Related]
25. Resolvin D5 Inhibits Neuropathic and Inflammatory Pain in Male But Not Female Mice: Distinct Actions of D-Series Resolvins in Chemotherapy-Induced Peripheral Neuropathy.
Luo X; Gu Y; Tao X; Serhan CN; Ji RR
Front Pharmacol; 2019; 10():745. PubMed ID: 31333464
[TBL] [Abstract][Full Text] [Related]
26. Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain.
Cuozzo M; Castelli V; Avagliano C; Cimini A; d'Angelo M; Cristiano C; Russo R
Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33808052
[TBL] [Abstract][Full Text] [Related]
27. Delta opioid receptors in Nav1.8 expressing peripheral neurons partially regulate the effect of delta agonist in models of migraine and opioid-induced hyperalgesia.
Bertels Z; Dripps IJ; Shah P; Moye LS; Tipton AF; Siegersma K; Pradhan AA
Neurobiol Pain; 2022; 12():100099. PubMed ID: 35859654
[TBL] [Abstract][Full Text] [Related]
28. Micromolar concentrations of rimonabant directly inhibits delta opioid receptor specific ligand binding and agonist-induced G-protein activity.
Zádor F; Kocsis D; Borsodi A; Benyhe S
Neurochem Int; 2014 Feb; 67():14-22. PubMed ID: 24508403
[TBL] [Abstract][Full Text] [Related]
29. Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in mice.
Basu A; Yang JY; Tsirukis VE; Loiacono A; Koch G; Khwaja IA; Krishnamurthy M; Fazio N; White E; Jha A; Shah S; Takmil C; Bagdas D; Demirer A; Master A; Natke E; Honkanen R; Huang L; Rigas B
Front Neurosci; 2023; 17():1240372. PubMed ID: 38347876
[TBL] [Abstract][Full Text] [Related]
30. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
Chine VB; Au NPB; Kumar G; Ma CHE
Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
[TBL] [Abstract][Full Text] [Related]
31. Central glucocorticoid receptors regulate the upregulation of spinal cannabinoid-1 receptors after peripheral nerve injury in rats.
Wang S; Lim G; Mao J; Sung B; Yang L; Mao J
Pain; 2007 Sep; 131(1-2):96-105. PubMed ID: 17258396
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological interventions targeting Wnt/β-catenin signaling pathway attenuate paclitaxel-induced peripheral neuropathy.
Resham K; Sharma SS
Eur J Pharmacol; 2019 Dec; 864():172714. PubMed ID: 31586636
[TBL] [Abstract][Full Text] [Related]
33. The pro-nociceptive effects of remifentanil or surgical injury in mice are associated with a decrease in delta-opioid receptor mRNA levels: Prevention of the nociceptive response by on-site delivery of enkephalins.
Cabañero D; Célérier E; García-Nogales P; Mata M; Roques BP; Maldonado R; Puig MM
Pain; 2009 Jan; 141(1-2):88-96. PubMed ID: 19058913
[TBL] [Abstract][Full Text] [Related]
34. Effects of peripheral nerve injury on delta opioid receptor (DOR) immunoreactivity in the rat spinal cord.
Stone LS; Vulchanova L; Riedl MS; Williams FG; Wilcox GL; Elde R
Neurosci Lett; 2004 May; 361(1-3):208-11. PubMed ID: 15135930
[TBL] [Abstract][Full Text] [Related]
35. Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain.
Kabli N; Cahill CM
Pain; 2007 Jan; 127(1-2):84-93. PubMed ID: 16963185
[TBL] [Abstract][Full Text] [Related]
36. Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain.
Pol O; Murtra P; Caracuel L; Valverde O; Puig MM; Maldonado R
Neuropharmacology; 2006 Jan; 50(1):123-32. PubMed ID: 16360182
[TBL] [Abstract][Full Text] [Related]
37. Plasticity of α2-adrenergic spinal antinociception following nerve injury: selective, bidirectional interaction with the delta opioid receptor.
Aira Z; Barrenetxea T; Buesa I; Azkue JJ
Brain Res; 2015 Jan; 1594():190-203. PubMed ID: 25446445
[TBL] [Abstract][Full Text] [Related]
38. Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study.
Velasco R; Navarro X; Gil-Gil M; Herrando-Grabulosa M; Calls A; Bruna J
J Pain Symptom Manage; 2017 Dec; 54(6):815-825. PubMed ID: 28797868
[TBL] [Abstract][Full Text] [Related]
39. Herbal Decoction Divya-Peedantak-Kwath Alleviates Allodynia and Hyperalgesia in Mice Model of Chemotherapy-Induced Peripheral Neuropathy via Modulation in Cytokine Response.
Balkrishna A; Sakat SS; Karumuri S; Singh H; Tomer M; Kumar A; Sharma N; Nain P; Haldar S; Varshney A
Front Pharmacol; 2020; 11():566490. PubMed ID: 33324205
[TBL] [Abstract][Full Text] [Related]
40. Preclinical research in paclitaxel-induced neuropathic pain: a systematic review.
Bacalhau C; Costa-Pereira JT; Tavares I
Front Vet Sci; 2023; 10():1264668. PubMed ID: 38188718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
